+Compare
INMD
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
1.89B

INMD InMode Ltd Forecast, Technical & Fundamental Analysis

a developer of minimally-invasive aesthetic medical products

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for INMD with price predictions
07:00 PM EST Dec 03, 2023

Momentum Indicator for INMD turns positive, indicating new upward trend

INMD saw its Momentum Indicator move above the 0 level on November 17, 2023. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 70 similar instances where the indicator turned positive. In of the 70 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for INMD just turned positive on October 30, 2023. Looking at past instances where INMD's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

INMD moved above its 50-day moving average on November 30, 2023 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INMD advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 231 cases where INMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INMD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. INMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.691) is normal, around the industry mean (25.181). P/E Ratio (11.136) is within average values for comparable stocks, (79.553). Projected Growth (PEG Ratio) (0.834) is also within normal values, averaging (6.249). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (4.029) is also within normal values, averaging (44.232).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.4B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 4%. For the same Industry, the average monthly price growth was 10%, and the average quarterly price growth was -10%. LNDZF experienced the highest price growth at 347%, while GENE experienced the biggest fall at -81%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -42%. For the same stocks of the Industry, the average monthly volume growth was -62% and the average quarterly volume growth was -43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 60
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: 19 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

INMD is expected to report earnings to rise 12.95% to 68 cents per share on February 08

InMode Ltd INMD Stock Earnings Reports
Q4'23
Est.
$0.69
Q3'23
Missed
by $0.04
Q2'23
Beat
by $0.07
Q1'23
Beat
by $0.06
Q4'22
Beat
by $0.11
The last earnings report on November 02 showed earnings per share of 61 cents, missing the estimate of 64 cents. With 1.70M shares outstanding, the current market capitalization sits at 1.89B.
A.I. Advisor
published General Information

General Information

a developer of minimally-invasive aesthetic medical products

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
Tavor Building, Sha’ar Yokneam
Phone
+972 49096313
Employees
480
Web
https://www.inmodemd.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSCRX16.53N/A
N/A
PGIM Jennison Small Company R
IDIVX15.81N/A
N/A
Integrity Dividend Harvest A
AIVAX18.55N/A
N/A
Virtus NFJ International Value Admin
RSLDX62.99N/A
N/A
American Funds SMALLCAP World R5E
VYCFX21.48N/A
N/A
Voya Corporate Leaders 100 R

INMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, INMD has been loosely correlated with IDXX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if INMD jumps, then IDXX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INMD
1D Price
Change %
INMD100%
+0.61%
IDXX - INMD
56%
Loosely correlated
+7.05%
TFX - INMD
50%
Loosely correlated
+0.76%
TWST - INMD
48%
Loosely correlated
+3.27%
ISRG - INMD
48%
Loosely correlated
-1.07%
RVTY - INMD
45%
Loosely correlated
+0.57%
More

Groups containing INMD

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INMD
1D Price
Change %
INMD100%
+0.61%
Medical Specialties
(undefined stocks)
54%
Loosely correlated
+0.47%
Medical Specialties
(undefined stocks)
54%
Loosely correlated
+0.47%
middle east
(undefined stocks)
50%
Loosely correlated
+0.96%